Gender-related differences in response to mutagens and carcinogens

Mutagenesis

Volumn 25, Issue 3, 2010, Pages 213-221

  Kirsch Volders, M ^a   Bonassi, S ^b   Herceg, Z ^c   Hirvonen, A ^d   Moller L ^e   Phillips, D H ^f  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e KAROLINSKA INSTITUTE   (Sweden)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BIOLOGICAL MARKER; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GLUTATHIONE TRANSFERASE M1; MESSENGER RNA; MUTAGENIC AGENT; SULFOTRANSFERASE 1A1;

AGE DISTRIBUTION; BEHAVIOR; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMATID EXCHANGE; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; DNA METHYLATION; DNA REPAIR; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTOXICITY; GENOTYPE; HEREDITY; HORMONE ACTION; HUMAN; LIFESTYLE; LUNG CANCER; MALE; MICRONUCLEUS TEST; NOTE; ONCOGENE K RAS; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; X CHROMOSOME; Y CHROMOSOME;

CARCINOGENS; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; DNA DAMAGE; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTAGENS; NEOPLASMS; SEX CHARACTERISTICS; SMOKING;

EID: 77952106538     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq008     Document Type: Note

References (77)

1. Vallender, E. J., Pearson, N. M. and Lahn, B. T. (2005) The X chromosome: not just her brother's keeper. Nat. Genet., 37, 343-345.
2. Carrel, L. and Willard, H. F. (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature, 434, 400-404.
3. Reik, W. and Lewis, A. (2005) Co-evolution of X-chromosome inactivation and imprinting in mammals. Nat. Rev. Genet., 6, 403-410.
4. Lercher, M. J., Urrutia, A. O. and Hurst, L. D. (2003) Evidence that the human X chromosome is enriched for male-specific but not female-specific genes. Mol. Biol. Evol., 20, 1113-1116.
5. Saifi, G. M. and Chandra, H. S. (1999) An apparent excess of sex-and reproduction-related genes on the human X chromosome. Proc. Biol. Sci., 266, 203-209.
6. Wang , P. J., McCarrey, J. R., Yang, F. and Page, D. C. (2001) An abundance of X-linked genes expressed in spermatogonia. Nat. Genet., 27, 422-426.
7. Ross, M. T., Grafham, D. V., Coffey, A. J. et al. (2005) The DNA sequence of the human X chromosome. Nature, 434, 325-337.
8. Khil, P. P., Smirnova, N. A., Romanienko, P. J. and Camerini-Otero, R. D. (2004) The mouse X chromosome is enriched for sex-biased genes not subject to selection by meiotic sex chromosome inactivation. Nat. Genet., 36, 642-646.
9. Vallender, E. J. and Lahn, B. T. (2004) How mammalian sex chromosomes acquired their peculiar gene content. Bioessays, 26, 159-169.
10. Nguyen, D. K. and Disteche, C. M. (2006) Dosage compensation of the active X chromosome in mammals. Nat. Genet., 38, 47-53.
11. Zechner, U., Wilda, M., Kehrer-Sawatzki, H., Vogel, W., Fundele, R. and Hameister, H. (2001) A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution? Trends Genet., 17, 697-701.
12. Hando, J. C., Nath, J. and Tucker, J. D. (1994) Sex chromosomes, micronuclei and aging in women. Chromosoma, 103, 186-192.
13. Surralles, J., Hande, M. P., Marcos, R. and Lansdorp, P. M. (1999) Accelerated telomere shortening in the human inactive X chromosome. Am. J. Hum. Genet., 65, 1617-1622.
14. Surralles, J., Jeppesen, P., Morrison, H. and Natarajan, A. T. (1996) Analysis of loss of inactive X chromosomes in interphase cells. Am. J. Hum. Genet., 59, 1091-1096.
15. Cook, M. B., Dawsey, S. M., Freedman, N. D., Inskip, P. D., Wichner, S. M., Quraishi, S. M., Devesa, S. S. and McGlynn, K. A. (2009) Sex disparities in cancer incidence by period and age. Cancer Epidemiol. Biomarkers Prev., 18, 1174-1182.
16. Kilfoy, B. A., Devesa, S. S., Ward, M. H., Zhang, Y., Rosenberg, P. S., Holford, T. R. and Anderson, W. F. (2009) Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol. Biomarkers Prev., 18, 1092-1100.
17. Higginson, J., Muir, C. S. and Muñoz, N. (1992) Human cancer: epidemiology and environmental causes. In Cambridge Monographs on Cancer Research. Cambridge University Press, Cambridge UK, 377-387.
18. Kedes, D. H., Ganem, D., Ameli, N., Bacchetti, P. and Greenblatt, R. (1997) The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA, 277, 478-481.
19. Pogoda, J. M. and Preston-Martin, S. (1996) Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control, 7, 458-463.
20. -(2002) Dietary Survey Report 1997-1998 of the Swedish Population. Swedish Food Administration, Uppsala, Sweden.
21. WCRF (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. World Cancer Research Fund, Washington DC, USA.
22. Bonassi, S., Bolognesi, C., Abbondandolo, A. et al. (1995) Influence of sex on cytogenetic end points: evidence from a large human sample and review of the literature. Cancer Epidemiol. Biomarkers Prev., 4, 671-679.
23. Bonassi, S., Fenech, M., Lando, C. et al. (2001) HUman MicroNucleus project: international database comparison for results with the cytokinesisblock micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ. Mol. Mutagen., 37, 31-45.
24. Fenech, M., Neville, S. and Rinaldi, J. (1994) Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. Mutat. Res., 313, 203-207.
25. (1990) A Nordic data base on somatic chromosome damage in humans. Nordic Study Group on the Health Risk of Chromosome Damage. Mutat. Res., 241, 325-337.
26. Catalan, J., Surralles, J., Falck, G. C., Autio, K. and Norppa, H. (2000) Segregation of sex chromosomes in human lymphocytes. Mutagenesis, 15, 251-255.
27. Neri, M., Ceppi, M., Knudsen, L. E., Merlo, D. F., Barale, R., Puntoni, R. and Bonassi, S. (2005) Baseline micronuclei frequency in children: estimates from meta-and pooled analyses. Environ. Health Perspect., 113, 1226-1229.
28. Baeyens, A., Vandersickel, V., Thierens, H., Ridder, L. D. and Vral, A. (2005) Effects of estradiol and progesterone on the variability of the micronucleus assay. Mutat. Res., 578, 308-316.
29. Kayani, M. A. and Parry, J. M. (2008) The detection and assessment of the aneugenic potential of selected oestrogens, progestins and androgens using the in vitro cytokinesis blocked micronucleus assay. Mutat. Res., 651, 40-45.
30. Fenech, M. (2007) Cytokinesis-block micronucleus cytome assay. Nat. Protoc., 2, 1084-1104.
31. Thomas, P., Holland, N., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., Zeiger, E., Knasmueller, S. and Fenech, M. (2009) Buccal micronucleus cytome assay. Nat. Protoc., 4, 825-837.
32. Holland, N., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., Zeiger, E., Knasmueller, S. and Fenech, M. (2008) The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutat. Res., 659, 93-108.
33. Bonassi, S., Biasotti, B., Kirsch-Volders, M. et al. (2009) State of the art survey of the buccal micronucleus assay-a first stage in the HUMN (XL) project initiative. Mutagenesis, 24, 295-302.
34. Fenech, M., Bolognesi, C., Kirsch-Volders, M., Bonassi, S., Zeiger, E., Knasmuller, S. and Holland, N. (2007) Harmonisation of the micronucleus assay in human buccal cells-a Human Micronucleus (HUMN) project initiative (www.humn.org) commencing in 2007. Mutagenesis, 22, 3-4.
35. Bonassi, S., Norppa, H., Ceppi, M. et al. (2008) Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries. Carcinogenesis, 29, 1178-1183.
36. Bonassi, S., Znaor, A., Ceppi, M. et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625-631.
37. van Leeuwen, D. M., van Herwijnen, M. H., Pedersen, M. et al. (2006) Genome-wide differential gene expression in children exposed to air pollution in the Czech Republic. Mutat. Res., 600, 12-22.
38. Patel, J. D. (2005) Lung cancer in women. J. Clin. Oncol., 23, 3212-3218.
39. Pope, M., Ashley, M. J. and Ferrence, R. (1999) The carcinogenic and toxic effects of tobacco smoke: are women particularly susceptible? J. Gend. Specif. Med., 2, 45-51.
40. Risch, H. A., Howe, G. R., Jain, M., Burch, J. D., Holowaty, E. J. and Miller, A. B. (1993) Are female smokers at greater risk for lung cancer than male smokers? Am. J. Epidemiol., 138, 281-293.
41. Zang, E. A. and Wynder, E. L. (1992) Cumulative tar exposure: a new index for estimating lung cancer risk among cigarette smokers. Cancer, 70, 69-76.
42. Harris, R. E., Zang, E. A., Anderson, J. I. and Wynder, E. L. (1993) Race and sex differences in lung cancer risk associated with cigarette smoking. Int. J. Epidemiol., 22, 592-599.
43. Tulinius, H., Sigfusson, N., Sigvaldason, H., Bjarnadottir, K. and Tryggvadottir, L. (1997) Risk factors for malignant diseases: a cohort study on a population of 22, 946 Icelanders. Cancer Epidemiol. Biomarkers Prev., 6, 863-873.
44. Henschke, C. I., Yip, R. and Miettinen, O. S. (2006) Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA, 296, 180-184.
45. Engeland, A. (1996) Trends in the incidence of smoking-associated cancers in Norway, 1954-93. Int. J. Cancer, 68, 39-46.
46. Kreuzer, M., Boffetta, P., Whitley, E. et al. (2000) Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br. J. Cancer, 82, 227-233.
47. Prescott, E., Osler, M., Hein, H. O., Borch-Johnsen, K., Lange, P., Schnohr, P. and Vestbo, J. (1998) Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology, 9, 79-83.
48. Bain, C., Feskanich, D., Speizer, F. E., Thun, M., Hertzmark, E., Rosner, B. A. and Colditz, G. A. (2004) Lung cancer rates in men and women with comparable histories of smoking. J. Natl Cancer Inst., 96, 826-834.
49. Perneger, T. V. (2001) Sex, smoking, and cancer: a reappraisal. J. Natl Cancer Inst., 93, 1600-1602.
50. Haugen, A. (2002) Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis, 23, 227-229.
51. Mollerup, S., Ryberg, D., Hewer, A., Phillips, D. H. and Haugen, A. (1999) Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. Cancer Res., 59, 3317-3320.
52. Berge, G., Mollerup, S., ØvrebØ, S., Hewer, A., Phillips, D. H., Eilertsen, E. and Haugen, A. (2004) Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer, 45, 289-297.
53. Meisel, P., Krause, T., Cascorbi, I., Schroeder, W., Herrmann, F., John, U. and Kocher, T. (2002) Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles. Genes Immun., 3, 102-106.
54. Wei, Q., Cheng, L., Amos, C. I., Wang, L. E., Guo, Z., Hong, W. K. and Spitz, M. R. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
55. Tang, D. L., Rundle, A., Warburton, D., Santella, R. M., Tsai, W.-Y., Chiamprasert, S., Hsu, Y. Z. and Perera, F. P. (1998) Associations between genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis, 19, 1949-1953.
56. Toyooka, S., Tsuda, T. and Gazdar, A. F. (2003) The TP53 gene, tobacco exposure, and lung cancer. Hum. Mutat., 21, 229-239.
57. Guinee, D. G., Jr., Travis, W. D., Trivers, G. E. et al. (1995) Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. Carcinogenesis, 16, 993-1002.
58. Kure, E. H., Ryberg, D., Hewer, A., Phillips, D. H., Skaug, V., Bæra, R. and Haugen, A. (1996) p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis, 17, 2201-2205.
59. Shriver, S. P., Bourdeau, H. A., Gubish, C. T., Tirpak, D. L., Davis, A. L., Luketich, J. D. and Siegfried, J. M. (2000) Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J. Natl Cancer Inst., 92, 24-33.
60. Aldridge, J. E., Gibbons, J. A., Flaherty, M. M., Kreider, M. L., Romano, J. A. and Levin, E. D. (2003) Heterogeneity of toxicant response: sources of human variability. Toxicol. Sci., 76, 3-20.
61. Battershill, J. M., Burnett, K. and Bull, S. (2008) Factors affecting the incidence of genotoxicity biomarkers in peripheral blood lymphocytes: impact on design of biomonitoring studies. Mutagenesis, 23, 423-437.
62. Iarmarcovai, G., Bonassi, S., Botta, A., Baan, R. A. and Orsiere, T. (2008) Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat. Res., 658, 215-233.
63. Vineis, P., Veglia, F., Benhamou, S. et al. (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer, 104, 650-657. (Pubitemid 36337268)
64. Loktionov, A., Watson, M. A., Gunter, M., Stebbings, W. S., Speakman, C. T. and Bingham, S. A. (2001) Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis, 22, 1053-1060.
65. Huang, C. C., Chien, W. P., Wong, R. H., Cheng, Y. W., Chen, M. C., Chou, M. C. and Lee, H. (2007) NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan. Dis. Colon Rectum, 50, 981-989.
66. Huang, C. C., Chien, W. P., Wong, R. H., Cheng, Y. W., Chen, M. C. and Lee, H. (2009) NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer. Environ. Mol. Mutagen., 50, 127-133.
67. Zheng, L., Wang, Y., Schabath, M. B., Grossman, H. B. and Wu, X. (2003) Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Lett., 202, 61-69.
68. Kaminsky, Z., Wang, S. C. and Petronis, A. (2006) Complex disease, gender and epigenetics. Ann. Med, 38, 530-544.
69. Sawan, C., Vaissiere, T., Murr, R. and Herceg, Z. (2008) Epigenetic drivers and genetic passengers on the road to cancer. Mutat. Res., 642, 1-13.
70. Vaissiere, T., Sawan, C. and Herceg, Z. (2008) Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat. Res., 659, 40-48.
71. Jones, P. A. and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
72. Delaval, K. and Feil, R. (2004) Epigenetic regulation of mammalian genomic imprinting. Curr. Opin. Genet. Dev., 14, 188-195.
73. Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H. and Jaenisch, R. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300, 489-492.
74. Robertson, K. D. and Jones, P. A. (2000) DNA methylation: past, present and future directions. Carcinogenesis, 21, 461-467.
75. Eckhardt, F., Lewin, J., Cortese, R. et al. (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet., 38, 1378-1385.
76. Saluz, H. P., Jiricny, J. and Jost, J. P. (1986) Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding sites and the rate of avian vitellogenin mRNA synthesis. Proc. Natl Acad. Sci. USA, 83, 7167-7171.
77. Kinyamu, H. K. and Archer, T. K. (2004) Modifying chromatin to permit steroid hormone receptor-dependent transcription. Biochim. Biophys. Acta, 1677, 30-45.